40T — ISEC Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- SG$238.41m
- SG$232.95m
- SG$69.99m
- 96
- 48
- 76
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9.9 | 6.51 | 9.09 | 16.8 | 17.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.998 | 1.53 | 0.193 | 0.539 | 0.459 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.38 | -3.42 | -0.229 | -2.92 | -4.49 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 11.7 | 7.87 | 12.3 | 17.8 | 17.2 |
Capital Expenditures | -1.36 | -2.42 | -0.791 | -5.71 | -3.52 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.487 | -2.65 | -1.55 | -5.88 | -2.92 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.876 | -5.07 | -2.34 | -11.6 | -6.43 |
Financing Cash Flow Items | 0.321 | 0.046 | -0.254 | -0.086 | 0.739 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -12.2 | -4.34 | -11.3 | -7.17 | -11.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.45 | -1.53 | -1.63 | -1.86 | -1.23 |